{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:39:48Z","timestamp":1792193988070,"version":"4.4.0"},"reference-count":13,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.contraception.2008.06.009","type":"journal-article","created":{"date-parts":[[2008,8,29]],"date-time":"2008-08-29T09:05:34Z","timestamp":1220000734000},"page":"399-404","source":"Crossref","is-referenced-by-count":8,"title":["Impact analysis of the discontinuation of reimbursement: the case of oral contraceptives"],"prefix":"10.1016","volume":"78","author":[{"given":"Pieter","family":"Stolk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Schneeweiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert G.M.","family":"Leufkens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eibert R.","family":"Heerdink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2008.06.009_bib1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2165\/00019053-200321020-00002","article-title":"European healthcare policies for controlling drug expenditure","volume":"21","author":"Ess","year":"2003","journal-title":"Pharmacoeconomics"},{"issue":"2","key":"10.1016\/j.contraception.2008.06.009_bib2","first-page":"CD005979","article-title":"Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies","author":"Aaserud","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"suppl 1","key":"10.1016\/j.contraception.2008.06.009_bib3","doi-asserted-by":"crossref","first-page":"s15","DOI":"10.1136\/bmj.39051.582546.94","article-title":"The pill: emblem of liberation","volume":"334","author":"Djerassi","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2008.06.009_bib4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s10198-004-0271-0","article-title":"Criteria for determining a basic health services package \u2014 recent developments in the Netherlands","volume":"50","author":"Stolk","year":"2005","journal-title":"Eur J Health Econom"},{"key":"10.1016\/j.contraception.2008.06.009_bib5","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/hpm.819","article-title":"Regulating the Dutch pharmaceutical market: improving efficiency or controlling costs?","volume":"20","author":"De Wolf","year":"2005","journal-title":"Int J Health Plann Man"},{"key":"10.1016\/j.contraception.2008.06.009_bib6","author":"Facts and figures 2006"},{"key":"10.1016\/j.contraception.2008.06.009_bib7","author":"WHO Collaborating Centre for Drug Statistics Methodology"},{"key":"10.1016\/j.contraception.2008.06.009_bib8","first-page":"S310","article-title":"Rapid monitoring of drug discontinuation rates in response to restrictions in drug reimbursement","volume":"13","author":"Dormuth","year":"2004","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.contraception.2008.06.009_bib9","article-title":"The pill","volume":"1307","author":"Foundation for Pharmaceutical Statistics (SFK)","year":"2005","journal-title":"Pharm Weekbl"},{"key":"10.1016\/j.contraception.2008.06.009_bib10","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/bmj.323.7305.131","article-title":"Third generation oral contraceptives and risk of venous thrombosis: meta-analysis","volume":"323","author":"Kemmeren","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2008.06.009_bib11","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF01983348","article-title":"The dynamics of oral contraceptive use in the Netherlands 1990\u20131993","volume":"10","author":"Oddens","year":"1994","journal-title":"Adv Contracept"},{"key":"10.1016\/j.contraception.2008.06.009_bib12","doi-asserted-by":"crossref","DOI":"10.1007\/s00228-007-0459-1","article-title":"Lipid-lowering drug use in Italian primary care: effects of reimbursement criteria revision","author":"Trifiro","year":"2008","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.contraception.2008.06.009_bib13","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s002280000169","article-title":"Consequences of a change in reimbursement status on prescription patterns","volume":"56","author":"Bouvy","year":"2000","journal-title":"Eur J Clin Pharmacol"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782408003399?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782408003399?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,26]],"date-time":"2018-12-26T06:50:29Z","timestamp":1545807029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782408003399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0010782408003399"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2008.06.009","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}